Poor glycemic control is linked to the development of microalbuminuria in childhood-onset type 1 diabetes.

Diabetics are at an increased risk when it comes to developing heart attacks and strokes. A new study finds lowering suggested targets for blood pressure and cholesterol levels beyond national guidelines may help prevent certain risk factors

Results from a new study reinforces the concept that the danger level for diabetics for heart attacks is the same as non-diabetics who already have had a heart attack.

Mast cell stabilizing therapy with topical cromolyn can reverse early injection-site lipoatrophy induced by human insulin analogs, and prevent further lesions.

For patients at risk of metabolic syndrome and type 2 diabetes, the Chinese exercises Tai Chi and Qigong may improve clinical parameters associated with the conditions, two small studies suggested.

Intake of soy protein had beneficial effects on cardiovascular risk factors and kidney-related biomarkers in patients with type 2 diabetes and nephropathy.

Lower cardiorespiratory fitness and higher body weight are independently associated with the development of type 2 diabetes in women, new research suggests.

Newly published data by Dr. J. Barthelow Classen in The Open Endocrinology Journal shows a 50% reduction of type 2 diabetes occurred in Japanese children following the discontinuation of a single vaccine to prevent tuberculosis.

Once-daily injections of insulin glargine (Lantus) may control type 2 diabetes as well as multiple injections of insulin lispro (Humalog) and reduce side effects at the same time, researchers found.

Diamyd Medical announced that the Swedish Medical Products Agency (MPA) in Europe and the FDA in the US, has approved the Company’s application to commence Phase III studies with the therapeutic diabetes vaccine Diamyd(R)